| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.79B | $1.46B | $1.36B |
| YoY Revenue Growth % | +22.4% | +7.8% | — |
| Gross Profit | $559.4M | $423.3M | — |
| Gross Margin % | 31.2% | 28.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $136.5M | $80.6M | $92.7M |
| Operating Margin % | 7.6% | 5.5% | 6.8% |
| Net Income (GAAP) | $42.2M | $28.5M | $34.4M |
| EBITDA (Normalized) | $167.5M | $115.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $57.4M | $76.7M | $144.3M |
| Capital Expenditures (CapEx) | $38.7M | $44.0M | — |
| Free Cash Flow (FCF) | $18.7M | $32.7M | $144.3M |
| FCF Margin % | 1.0% | 2.2% | 10.6% |
| Return on Invested Capital (ROIC %) | 8.6% | 5.8% | — |
| Cash & Short-Term Equivalents | — | $44.4M | — |
| Total Debt (Short + Long Term) | $566.7M | $535.2M | — |
| Total Stockholders' Equity | $683.7M | $615.7M | — |